Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma

Clinical and Experimental Immunology

Volumn 144, Issue 1, 2006, Pages 76-84

  Brimnes, M K ^a   Svane, I M ^a   Johnsen, H E ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Functionality; Multiple myeloma; Myeloid dendritic cells; Phenotypic profile; Plasmacytoid dendritic cells

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; HLA ANTIGEN; PROTEIN; PROTEIN DEC205; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; CELL COUNT; CELL DIVISION; CYTOKINES; DENDRITIC CELLS; HLA ANTIGENS; HUMANS; LECTINS, C-TYPE; MULTIPLE MYELOMA; MYELOID CELLS; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 33645098467     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03037.x     Document Type: Article

References (32)

1. Lokhorst HM Schattenberg A Cornelissen JJ et al. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome J Clin Oncol 2000 18 3031 7
2. Cavo M Terragna C Martinelli G et al. Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma Blood 2000 96 355 7
3. Socie G Current issues in allogeneic stem cell transplantation Hematology 2005 10 Suppl. 1 63
4. Steinman RM The dendritic cell system and its role in immunogenicity Annu Rev Immunol 1991 9 271 96
5. Banchereau J Steinman RM Dendritic cells and the control of immunity Nature 1998 392 245 52
6. Ridgway D The first 1000 dendritic cell vaccinees Cancer Invest 2003 21 873 86
7. Hawiger D Inaba K Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo J Exp Med 2001 194 769 79
8. Dhodapkar MV Steinman RM Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans Blood 2002 100 174 7
9. + T cell tolerance J Exp Med 2002 196 1627 38
10. Shortman K Liu YJ Mouse and human dendritic cell subtypes Nat Rev Immunol 2002 2 151 61
11. Fitzgerald-Bocarsly P Human natural interferon-alpha producing cells Pharmacol Ther 1993 60 39 62
12. McKenna K Beignon AS Bhardwaj N Plasmacytoid dendritic cells: linking innate and adaptive immunity J Virol 2005 79 17 27
13. de Heer HJ Hammad H Soullie T et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen J Exp Med 2004 200 89 98
14. Ratta M Fagnoni F Curti A et al. Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6 Blood 2002 100 230 7
15. Do TH Johnsen HE Kjaersgaard E Taaning E Svane IM Impaired circulating myeloid DCs from myeloma patients Cytotherapy 2004 6 196 203
16. Brown R Murray A Pope B et al. Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma Br J Haematol 2004 125 743 8
17. Brown RD Pope B Murray A et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10 Blood 2001 98 2992 8
18. Raje N Gong J Chauhan D et al. Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequences Blood 1999 93 1487 95
19. Caux C Ait-Yahia S Chemin K et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines Springer Semin Immunopathol 2000 22 345 69
20. Jiang W Swiggard WJ Heufler C et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing Nature 1995 375 151 5
21. Mahnke K Guo M Lee S et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments J Cell Biol 2000 151 673 84
22. Orsini E Guarini A Chiaretti S Mauro FR Foa R The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response Cancer Res 2003 63 4497 506
23. Orsini E Pasquale A Maggio R et al. Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro Br J Haematol 2004 125 720 8
24. Boissel N Rousselot P Raffoux E et al. Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate Leukemia 2004 18 1656 61
25. Bourguin-Plonquet A Rouard H Roudot-Thoraval F et al. Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia Br J Haematol 2002 116 595 7
26. Mohty M Jarrossay D Lafage-Pochitaloff M et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment Blood 2001 98 3750 6
27. Almand B Resser JR Lindman B et al. Clinical significance of defective dendritic cell differentiation in cancer Clin Cancer Res 2000 6 1755 66
28. Della BS Gennaro M Vaccari M et al. Altered maturation of peripheral blood dendritic cells in patients with breast cancer Br J Cancer 2003 89 1463 72
29. Gabrilovich DI Corak J Ciernik IF Kavanaugh D Carbone DP Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 1997 3 483 90
30. Satthaporn S Robins A Vassanasiri W et al. Dendritic cells are dysfunctional in patients with operable breast cancer Cancer Immunol Immunother 2004 53 510 8
31. Vuillier F Maloum K Thomas EK Jouanne C Dighiero G Scott-Algara D Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia Br J Haematol 2001 115 831 44
32. Rezvany MR Jeddi-Tehrani M Biberfeld P et al. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern Br J Haematol 2001 115 263 71